Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMC Cancer|December 24, 2010
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer AssayKim M Clark-Langone, Chithra Sangli, Jayadevi Krishnakumar, et al.
Gene|April 12, 2002
Differences in nuclear gene expression between cells containing monomer and dimer mitochondrial genomesKim M Clark, Timothy A Brown, Mercy M Davidson, et al.
Breast Cancer Research and Treatment|September 21, 2004
EGFR and EGFRvIII expression in primary breast cancer and cell linesJames M Rae, Joshua O Scheys, Kim M Clark, et al.
Plos One|March 31, 2025
Tissue of origin characterization of cell free DNA in seminal plasma: Implications for new liquid biopsiesStephanie Huang, James C Hart, James F Smith, et al.
Nature Genetics|January 19, 2002
Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutationRobert McFarland, Kim M Clark, Andrew A M Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatinGreg Yothers, Michael J O'Connell, Mark Lee, et al.
BMC Genomics|August 19, 2007
Biomarker discovery for colon cancer using a 761 gene RT-PCR assayKim M Clark-Langone, Jenny Y Wu, Chithra Sangli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorinMichael J O'Connell, Ian Lavery, Greg Yothers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2011
Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancerRichard G Gray, Philip Quirke, Kelly Handley, et al.
Pageof 1